The Hidden Cost of Price Control Policies w/ Kirsten Axelsen
The price control policies that are being discussed in Congress have the potential to harm innovation in the life science industry. But how, exactly?
In this episode, we interview Kirsten Axelsen, Senior Advisor at Charles Rivers Associates , about what would change in biopharma if price controls were implemented.
In this episode, we discuss:
The close relationship between economy and drug development
The U.S.’s role in developing over 40% of the world’s new medicines
The potential reduction of biopharma global revenues by 19%
What it means globally when 8-15 fewer medicines are made per…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.